CN106539093A - A kind of gene repair fully nutrient - Google Patents
A kind of gene repair fully nutrient Download PDFInfo
- Publication number
- CN106539093A CN106539093A CN201710025118.3A CN201710025118A CN106539093A CN 106539093 A CN106539093 A CN 106539093A CN 201710025118 A CN201710025118 A CN 201710025118A CN 106539093 A CN106539093 A CN 106539093A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- soluble
- fully nutrient
- gene repair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 37
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 31
- 230000008439 repair process Effects 0.000 title claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 229940088594 vitamin Drugs 0.000 claims abstract description 21
- 229930003231 vitamin Natural products 0.000 claims abstract description 21
- 235000013343 vitamin Nutrition 0.000 claims abstract description 21
- 239000011782 vitamin Substances 0.000 claims abstract description 21
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 21
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 19
- 235000003969 glutathione Nutrition 0.000 claims abstract description 19
- 229960003180 glutathione Drugs 0.000 claims abstract description 19
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims abstract description 18
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims abstract description 17
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 claims abstract description 16
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims abstract description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000004212 Cryptoxanthin Substances 0.000 claims abstract description 16
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 16
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 16
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000002360 beta-cryptoxanthin Nutrition 0.000 claims abstract description 16
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 claims abstract description 16
- 235000019244 cryptoxanthin Nutrition 0.000 claims abstract description 16
- 235000019136 lipoic acid Nutrition 0.000 claims abstract description 16
- 235000012661 lycopene Nutrition 0.000 claims abstract description 16
- 239000001751 lycopene Substances 0.000 claims abstract description 16
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 16
- 229960004999 lycopene Drugs 0.000 claims abstract description 16
- 229960002663 thioctic acid Drugs 0.000 claims abstract description 16
- 239000011573 trace mineral Substances 0.000 claims abstract description 16
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 16
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 14
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 14
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229940119429 cocoa extract Drugs 0.000 claims abstract description 11
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 11
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 8
- 229940046009 vitamin E Drugs 0.000 claims abstract description 8
- 239000011709 vitamin E Substances 0.000 claims abstract description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 7
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 7
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 7
- 229960000304 folic acid Drugs 0.000 claims abstract description 7
- 239000011724 folic acid Substances 0.000 claims abstract description 7
- 235000019152 folic acid Nutrition 0.000 claims abstract description 7
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 7
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 7
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 7
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 7
- 239000011719 vitamin A Substances 0.000 claims abstract description 7
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 7
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 7
- 239000011718 vitamin C Substances 0.000 claims abstract description 7
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 7
- 239000011710 vitamin D Substances 0.000 claims abstract description 7
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 7
- 239000011728 vitamin K2 Substances 0.000 claims abstract description 7
- 229940045997 vitamin a Drugs 0.000 claims abstract description 7
- 229940046008 vitamin d Drugs 0.000 claims abstract description 7
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000011575 calcium Substances 0.000 claims abstract description 5
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 5
- 229910052802 copper Inorganic materials 0.000 claims abstract description 5
- 239000010949 copper Substances 0.000 claims abstract description 5
- 239000011630 iodine Substances 0.000 claims abstract description 5
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 5
- 229910052742 iron Inorganic materials 0.000 claims abstract description 5
- 239000011777 magnesium Substances 0.000 claims abstract description 5
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 5
- 239000011669 selenium Substances 0.000 claims abstract description 5
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 3
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 claims abstract 2
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical group [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 18
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical group [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 6
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical group [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 6
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical group [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 6
- 239000011781 sodium selenite Substances 0.000 claims description 6
- 229960001471 sodium selenite Drugs 0.000 claims description 6
- 235000015921 sodium selenite Nutrition 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- KSNGEYQWLMRSIR-UHFFFAOYSA-L 2-hydroxypropanoate;manganese(2+) Chemical compound [Mn+2].CC(O)C([O-])=O.CC(O)C([O-])=O KSNGEYQWLMRSIR-UHFFFAOYSA-L 0.000 claims description 4
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims description 4
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 4
- QXDHJHQRJCJRAU-UHFFFAOYSA-N calcium;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Ca].OC(=O)CC(O)(C(O)=O)CC(O)=O QXDHJHQRJCJRAU-UHFFFAOYSA-N 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 235000013925 ferrous lactate Nutrition 0.000 claims description 4
- 239000004225 ferrous lactate Substances 0.000 claims description 4
- 229940037907 ferrous lactate Drugs 0.000 claims description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 229910052748 manganese Inorganic materials 0.000 claims description 4
- 239000011572 manganese Substances 0.000 claims description 4
- 229940099596 manganese sulfate Drugs 0.000 claims description 4
- 239000011702 manganese sulphate Substances 0.000 claims description 4
- 235000007079 manganese sulphate Nutrition 0.000 claims description 4
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical group [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 4
- 229940091258 selenium supplement Drugs 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 3
- 239000001354 calcium citrate Substances 0.000 claims description 3
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 claims 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims 1
- 235000009754 Vitis X bourquina Nutrition 0.000 claims 1
- 235000012333 Vitis X labruscana Nutrition 0.000 claims 1
- 240000006365 Vitis vinifera Species 0.000 claims 1
- 235000014787 Vitis vinifera Nutrition 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 16
- 201000011510 cancer Diseases 0.000 abstract description 12
- 230000005778 DNA damage Effects 0.000 abstract description 5
- 231100000277 DNA damage Toxicity 0.000 abstract description 5
- 238000011278 co-treatment Methods 0.000 abstract description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 abstract 1
- -1 0.35 part of ferment Chemical compound 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 230000006378 damage Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 206010064571 Gene mutation Diseases 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 235000009470 Theobroma cacao Nutrition 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 201000011529 cardiovascular cancer Diseases 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 108700020463 BRCA1 Proteins 0.000 description 1
- 102000036365 BRCA1 Human genes 0.000 description 1
- 101150072950 BRCA1 gene Proteins 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 108700025695 Suppressor Genes Proteins 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015015 brainstem development Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 230000008271 nervous system development Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to biological health-care product field, and in particular to a kind of glutathion fully nutrient, including the raw material of following weight parts：68 parts of glutathion, 25 parts of vitamin, 23 parts of trace element, ubiquinone10 1.5 2.5 parts, 1 2.5 parts of unsaturated fatty acid, 0.5 1 parts of thioctic acid, 0.2 0.5 parts of ferment, 0.05 0.2 parts of cryptoxanthin, 13 parts of cocoa extract, 0.05 0.3 parts of lycopene, the vitamin is by vitamin A, vitamin D, vitamin C, Vitamin E, vitamin K2, vitamin B12, nicotinic acid, Folic Acid composition, the trace element is made up of solubility calcium, soluble magnesium, soluble iron, soluble copper, iodine soluble, soluble manganese, soluble selenium, gene repair fully nutrient of the present invention can improve the repair ability of DNA damage, can be used for the high risk group of normal population, cancer, to prevent cancer from occurring, can be used for cancer patient, co-treatment, convenient oral again.
Description
Technical field
The present invention relates to biological health-care product field, and in particular to a kind of gene repair fully nutrient.
Background technology
Various cancers are all due to repairing after DNA damage, cause gene mutation to cause.Under normal circumstances, in human body
Substantial amounts of oxyradical is produced, causes DNA damage, external ultraviolet, smoking, virus infection, environmental pollution etc. also damage
DNA is done harm to, but the repair mechanism of human normal can be repaired.When human senility or reparation function decline, gene mutation can be caused, caused
Cancer.Not yet there are all necessary nutrient health cares for maintaining human body gene reparation and preventing gene damage in the market
Product.
The content of the invention
The invention provides a kind of gene repair fully nutrient, the fully nutrient has to reduce and can cause DNA damage
The ability that the ability and enhancing DNA of free radical is repaired, can be used for the high risk group of normal population, cancer, to prevent cancer from sending out
It is raw, can be used for cancer patient again, co-treatment is nontoxic, convenient oral.
To realize object above, the present invention is achieved by the following technical programs：
A kind of gene repair fully nutrient, including the raw material of following weight parts：It is glutathion 6-8 parts, vitamin 2-5 parts, micro
Element 2-3 parts, ubiquinone10 1.5-2.5 parts, unsaturated fatty acid 1-2.5 parts, thioctic acid 0.5-1 parts, ferment 0.2-0.5 parts, jade
Cream-coloured matter 0.05-0.2 part, cocoa extract 1-3 parts, lycopene 0.05-0.3 parts.
Preferably, the gene repair fully nutrient includes the raw material of following weight parts：7 parts of glutathion, vitamin 3.5
Part, 2.5 parts of trace element, ubiquinone102 parts, 2 parts of unsaturated fatty acid, 0.8 part of thioctic acid, 0.35 part of ferment, cryptoxanthin
0.12 part, 2 parts of cocoa extract, 0.15 part of lycopene.
Preferably, the vitamin is made up of the raw material of following weight parts：Vitamin A 6-10 parts, vitamin D 2-5 parts,
Vitamin C 0.5-3 parts, Vitamin E 1-4 part, vitamin K20.4-1 parts, vitamin B120.05-0.3 parts, nicotinic acid 0.5-3
Part, Folic Acid 1-5 part.
Preferably, the trace element is made up of the raw material of following weight parts：Solubility calcium 12-15 parts, soluble magnesium 20-
35 parts, soluble iron 3-7 parts, soluble copper 1-3 parts, iodine soluble 0.05-0.1 parts, soluble manganese 0.05-0.1 part, solubility
Selenium 0.03-0.08 parts.
Preferably, the solubility calcium be Citric acid calcium, calcium chloride, the one kind in calcium citrate；The soluble magnesium is
One kind in magnesium chloride, magnesium sulfate；The soluble iron is Ferrous gluconate, the one kind in ferrous lactate；The solubility
Copper is copper sulfate；The iodine soluble is potassium iodide；The soluble manganese is manganese sulfate, the one kind in manganese lactate；It is described solvable
Property selenium be sodium selenite.
Preferably, the unsaturated fatty acid is n-3 polyunsaturated fatty acid.
Preferably, the fully nutrient also includes pharmaceutically acceptable adjuvant.
Preferably, the fully nutrient is pharmaceutically acceptable any type of product.
Preferably, the form of the product is capsule, tablet, granule or oral liquid.
Glutathion：Glutathion is the special effects materials for releasing toxin, is a kind of small molecule being made up of three aminoacid
Peptide, it is such as combined with free radical, heavy metal etc., so as to body as antioxidant important in vivo and free radical scavenger
Interior harmful poisonous substance is converted into harmless material, excretes external.The polyradical excessively that the new old generation metabolism of body is produced can be damaged
Biomembrane, attacks life macromolecule, accelerates body aging, and induced tumor or atherosclerotic generation.Glutathion exists
Chemical, biological defense system in human body plays an important role, with many physiological functions.Its major physiological effect is can be clear
The free radical in human body is removed, as a kind of internal important antioxidant, numerous protein and the mercapto in enzyme equimolecular is protected
Base.Glutathion can not only eliminate human free radical, can also improve body immunity.Glutathion maintaining healthy, defying age,
The effect played on the cell of old man's slowization is than the young National People's Congress.Glutathion can also protect hemoglobin not receive peroxide
Change the oxidation such as hydroxide, free radical so that it continues the normal ability for playing transport oxygen.
Ubiquinone10：Ubiquinone10（coenzymeQ10）Be have in human body cell the effect of important Physiology and biochemistry coenzyme it
One, it is the activator of cellular metabolism and Cellular respiration, it is important to can enhancing gene repair enzyme.
Unsaturated fatty acid：Unsaturated fatty acid is primarily referred to as from human diet oils and fatss, is health, nutrition institute
Need, and have found a group that there is positive preventive and therapeutic effect to the civilization of human society disease such as disease such as hypertension, heart disease, hyperlipidemia
Fatty acid, such as alpha-linolenic acid, linoleic acid, EPA, DHA etc..Wherein n-3 polyunsaturated fatty acid be the important nutrient of human body it
One, human body itself cannot synthesize, it is necessary to absorb from food.Increase n-3 polyunsaturated fatty acid intake and can promote baby children
Youngster's retina, brain and nervous system development；The generation of n-3 polyunsaturated fatty acid inflammation by all means, reduces glycosuria
Patient's serum LDL-C and TG level, can suppress mammary gland, prostate and the colon cancer cell hypertrophy of In vitro culture, promote cell
Apoptosis.
Thioctic acid：Thioctic acid is that one kind is present in mitochondrial coenzyme, is similar to vitamin, can eliminate accelerated ageing and cause a disease
Free radical.Thioctic acid enters cell after enteral road absorbs in vivo, have concurrently it is fat-soluble with water miscible characteristic, therefore can be
Whole body is gone everywhere without any hindrance here, and reaches any one cell area, there is provided the comprehensive efficiency of human body, is that tool is fat-soluble omnipotent anti-with water miscible
Oxidant.
Cryptoxanthin：Cryptoxanthin can cause cell and organ to free radical in human body as numerous carotenoid
Damage resisted.Research shows that cryptoxanthin is in the autoxidation for suppressing cytolipin and prevents from aoxidizing the cell for bringing
It is more more effective than beta-carotene in terms of damage, and the peroxidating of cytolipin is relevant with the growth of tumor, this explanation cryptoxanthin tool
The generation for being reduced cancer and the effect for strengthening immunologic function.
Cocoa extract：The research of Harvard University finds, can reduce the risk of the disease such as cardiovascular diseasess and cancer, prolong
Long-life, Vitamin E are topmost vitamin in cocoa, and procyanidin is topmost polyphenol in cocoa.They are main
Free radical scavenger, body can be protected to exempt from oxidative damage.Therefore, they are to various diseases, such as cardiovascular diseasess, cancer and
Aging has preventive effect.
Lycopene：Lycopene has prevention and function of tumor inhibition, is on the one hand because its antioxidation；Separately
On the one hand it is that lycopene can block histiocyte producer mutation process in the presence of extraneous mutagenic agent, this is tumor
One of important mechanisms of generation.
Beneficial effects of the present invention are：
1st, our research indicate that：DNA repair abilities can be caused to decline after suppressor gene p53 and BRCA1 mutation, be repaiied using gene
After multiple fully nutrient, the repair ability of DNA damage is significantly improved.Further study show that this gene repair fully nutrient can show
The veterinary cancer incidence rate after reducing Tumor Suppressor Gene Mutations is write, gene repair fully nutrient can be used for the height of normal population, cancer
Population at risk, to prevent cancer from occurring, can be used for cancer patient, co-treatment, convenient oral again.
2nd, fully nutrient formula of the present invention rationally, has no toxic side effect, not product poison, and free from extraneous odour never degenerates, human body is not had
Harmful additive, does not interfere with interference absorption of the human body to other nutrients.
Specific embodiment
The technical solution of the present invention is further illustrated with reference to specific embodiment, embodiment is not to be construed as right
The restriction of technical solution.
Embodiment 1：Capsule
A kind of gene repair fully nutrient, including the raw material of following weight parts：7 parts of glutathion, 3.5 parts of vitamin, micro unit
Plain 2.5 parts, ubiquinone102 parts, 2 parts of unsaturated fatty acid, 0.8 part of thioctic acid, 0.35 part of ferment, 0.12 part of cryptoxanthin, cocoa
2 parts of extract, 0.15 part of lycopene.
Said vitamin is made up of the raw material of following weight parts：10 parts of vitamin A, 3 parts of vitamin D, vitamin C 2
Part, 4 parts of Vitamin E, vitamin K20.8 part, vitamin B120.3 part, 0.5 part of nicotinic acid, 5 parts of Folic Acid.
Above-mentioned trace element is made up of the raw material of following weight parts：13 parts of Citric acid calcium, 28 parts of magnesium chloride, gluconic acid are sub-
7 parts of ferrum, 1 part of copper sulfate, 0.1 part of potassium iodide, 0.08 part of manganese sulfate, 0.05 part of sodium selenite.
The preparation method of the gene repair fully nutrient, comprises the following steps：By glutathion, vitamin, trace element,
Ubiquinone10, unsaturated fatty acid, thioctic acid, ferment, cryptoxanthin, cocoa extract, lycopene uniformly mix by formula ratio
Capsule is dressed up with conventional method afterwards.
Embodiment 2：Tablet
A kind of gene repair fully nutrient, including the raw material of following weight parts：8 parts of glutathion, 5 parts of vitamin, trace element 2
Part, ubiquinone10 2.5 parts, 2.5 parts of unsaturated fatty acid, 1 part of thioctic acid, 0.5 part of ferment, 0.05 part of cryptoxanthin, can extract
3 parts of thing, 0.05 part of lycopene.
Said vitamin is made up of the raw material of following weight parts：8 parts of vitamin A, 5 parts of vitamin D, 3 parts of vitamin C,
1 part of Vitamin E, vitamin K20.4 part, vitamin B120.05 part, 3 parts of nicotinic acid, 1 part of Folic Acid.
Above-mentioned trace element is made up of the raw material of following weight parts：15 parts of calcium chloride, 20 parts of magnesium sulfate, 7 parts of ferrous lactate,
3 parts of copper sulfate, 0.05 part of potassium iodide, 0.1 part of manganese lactate, 0.08 part of sodium selenite.
The preparation method of the gene repair fully nutrient tablet, comprises the following steps：By glutathion, vitamin, micro
Element, ubiquinone10, unsaturated fatty acid, thioctic acid, ferment, cryptoxanthin, cocoa extract, that lycopene presses formula ratio is uniform
Tablet is made with conventional method after mixing.
Embodiment 3：Granule
A kind of gene repair fully nutrient, including the raw material of following weight parts：8 parts of glutathion, 3 parts of vitamin, trace element 3
Part, ubiquinone102 parts, 1.5 parts of unsaturated fatty acid, 0.5 part of thioctic acid, 0.2 part of ferment, 0.2 part of cryptoxanthin, cocoa extract
1 part, 0.3 part of lycopene.
Said vitamin is made up of the raw material of following weight parts：6 parts of vitamin A, 2 parts of vitamin D, vitamin C 0.5
Part, 2 parts of Vitamin E, vitamin K20.6 part, vitamin B120.2 part, 2 parts of nicotinic acid, 3 parts of Folic Acid.
Above-mentioned trace element is made up of the raw material of following weight parts：12 parts of calcium citrate, 35 parts of magnesium chloride, ferrous lactate 3
Part, 1 part of copper sulfate, 0.1 part of potassium iodide, 0.05 part of manganese sulfate, 0.03 part of sodium selenite.
The preparation method of the gene repair fully nutrient granule, comprises the following steps：By glutathion, vitamin, micro-
Secondary element, ubiquinone10, unsaturated fatty acid, thioctic acid, ferment, cryptoxanthin, cocoa extract, that lycopene presses formula ratio is equal
Granule is made with conventional method after even mixing.
Embodiment 4：Oral liquid
A kind of gene repair fully nutrient, including the raw material of following weight parts：6 parts of glutathion, 2 parts of vitamin, trace element 3
Part, ubiquinone10 1.5 parts, 1 part of unsaturated fatty acid, 0.5 part of thioctic acid, 0.4 part of ferment, 0.15 part of cryptoxanthin, can extract
1 part of thing, 0.2 part of lycopene.
Said vitamin is made up of the raw material of following weight parts：7 parts of vitamin A, 4 parts of vitamin D, vitamin C 1
Part, 3 parts of Vitamin E, vitamin K21 part, vitamin B120.1 part, 1 part of nicotinic acid, 2 parts of Folic Acid.
Above-mentioned trace element is made up of the raw material of following weight parts：12 parts of Citric acid calcium, 25 parts of magnesium sulfate, gluconic acid are sub-
7 parts of ferrum, 1 part of copper sulfate, 0.05 part of potassium iodide, 0.06 part of manganese lactate, 0.06 part of sodium selenite.
The preparation method of the gene repair fully nutrient oral liquid, comprises the following steps：Add purified water in material-compound tank, rise
Temperature sequentially adds the glutathion of formula ratio, vitamin, trace element, ubiquinone while stirring to 65 DEG C10, unsaturated fatty acidss
Acid, thioctic acid, ferment, cryptoxanthin, cocoa extract, lycopene and appropriate correctivess Vc, correctivess A-K are sugared,
Oral liquid is made with conventional method afterwards.
It is more than the description to the embodiment of the present invention, by the foregoing description of the disclosed embodiments, makes this area special
Industry technical staff can realize or using the present invention.Various modifications to these embodiments come to those skilled in the art
Say and will be apparent, generic principles defined herein can be in the situation without departing from the spirit or scope of the present invention
Under, realize in other embodiments.Therefore, the present invention is not intended to be limited to the embodiments shown herein, but will accord with
Close the most wide scope consistent with principles disclosed herein and features of novelty.
Claims (9)
1. a kind of gene repair fully nutrient, it is characterised in that including the raw material of following weight parts：Glutathion 6-8 parts, dimension life
Plain 2-5 parts, trace element 2-3 parts, ubiquinone10 1.5-2.5 parts, unsaturated fatty acid 1-2.5 parts, thioctic acid 0.5-1 parts, ferment
0.2-0.5 parts, cryptoxanthin 0.05-0.2 parts, cocoa extract 1-3 parts, lycopene 0.05-0.3 parts.
2. gene repair fully nutrient according to claim 1, it is characterised in that including the raw material of following weight parts：Paddy
7 parts of the sweet peptide of Guang, 3.5 parts of vitamin, 2.5 parts of trace element, ubiquinone102 parts, 2 parts of unsaturated fatty acid, 0.8 part of thioctic acid, ferment
0.35 part of element, 0.12 part of cryptoxanthin, 2 parts of cocoa extract, 0.15 part of lycopene.
3. gene repair fully nutrient according to claim 1, it is characterised in that the vitamin is by following weight parts
Raw material is constituted：Vitamin A 6-10 parts, vitamin D 2-5 parts, vitamin C 0.5-3 parts, Vitamin E 1-4 part, vitamin K2
0.4-1 parts, vitamin B120.05-0.3 parts, nicotinic acid 0.5-3 parts, Folic Acid 1-5 part.
4. gene repair fully nutrient according to claim 1, it is characterised in that the trace element is by following weight parts
Raw material composition：Solubility calcium 12-15 parts, soluble magnesium 20-35 parts, soluble iron 3-7 parts, soluble copper 1-3 parts, solubility
Iodine 0.05-0.1 parts, soluble manganese 0.05-0.1 part, soluble selenium 0.03-0.08 part.
5. gene repair fully nutrient according to claim 4, it is characterised in that the solubility calcium be Citric acid calcium,
One kind in calcium chloride, calcium citrate；The soluble magnesium is magnesium chloride, the one kind in magnesium sulfate；The soluble iron is Portugal
One kind in grape saccharic acid ferrous iron, ferrous lactate；The soluble copper is copper sulfate；The iodine soluble is potassium iodide；It is described can
Dissolubility manganese is manganese sulfate, the one kind in manganese lactate；The soluble selenium is sodium selenite.
6. gene repair fully nutrient according to claim 1, it is characterised in that the unsaturated fatty acid is that n-3 is more
Unsaturated fatty acid.
7. the gene repair fully nutrient according to any one of claim 1-6, it is characterised in that the fully nutrient is also wrapped
Include pharmaceutically acceptable adjuvant.
8. gene repair fully nutrient according to claim 7, it is characterised in that the fully nutrient is can pharmaceutically to connect
Any type of product received.
9. gene repair fully nutrient according to claim 8, it is characterised in that the form of the product be capsule,
Tablet, granule or oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710025118.3A CN106539093A (en) | 2017-01-13 | 2017-01-13 | A kind of gene repair fully nutrient |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710025118.3A CN106539093A (en) | 2017-01-13 | 2017-01-13 | A kind of gene repair fully nutrient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106539093A true CN106539093A (en) | 2017-03-29 |
Family
ID=58398438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710025118.3A Pending CN106539093A (en) | 2017-01-13 | 2017-01-13 | A kind of gene repair fully nutrient |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106539093A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109874972A (en) * | 2019-04-08 | 2019-06-14 | 深圳津梁生活科技有限公司 | Multifunctional and nutritional compound health snack food |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1792256A (en) * | 2006-01-04 | 2006-06-28 | 张东杰 | Health-care food for preventing and improving lead poisoning, and its prepn. method |
| CN101543546A (en) * | 2008-03-28 | 2009-09-30 | 上海安普生物科技有限公司 | Antioxidative substance and composition and use thereof |
| CN102440386A (en) * | 2010-10-15 | 2012-05-09 | 胥永贵 | Full composite human body antioxidant |
| CN104366437A (en) * | 2014-11-11 | 2015-02-25 | 中国科学院青岛生物能源与过程研究所 | Table sauce enriched in n-3 polyunsaturated fatty acids and preparation method thereof |
| CN106036823A (en) * | 2016-05-23 | 2016-10-26 | 沈阳迪格医疗科技有限公司 | Health-care product and preparation method thereof |
| CN106072659A (en) * | 2016-06-29 | 2016-11-09 | 中国人民解放军第三军医大学第附属医院 | Multielement organism antioxidants compositions and application thereof |
-
2017
- 2017-01-13 CN CN201710025118.3A patent/CN106539093A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1792256A (en) * | 2006-01-04 | 2006-06-28 | 张东杰 | Health-care food for preventing and improving lead poisoning, and its prepn. method |
| CN101543546A (en) * | 2008-03-28 | 2009-09-30 | 上海安普生物科技有限公司 | Antioxidative substance and composition and use thereof |
| CN102440386A (en) * | 2010-10-15 | 2012-05-09 | 胥永贵 | Full composite human body antioxidant |
| CN104366437A (en) * | 2014-11-11 | 2015-02-25 | 中国科学院青岛生物能源与过程研究所 | Table sauce enriched in n-3 polyunsaturated fatty acids and preparation method thereof |
| CN106036823A (en) * | 2016-05-23 | 2016-10-26 | 沈阳迪格医疗科技有限公司 | Health-care product and preparation method thereof |
| CN106072659A (en) * | 2016-06-29 | 2016-11-09 | 中国人民解放军第三军医大学第附属医院 | Multielement organism antioxidants compositions and application thereof |
Non-Patent Citations (2)
| Title |
|---|
| 刘建春: "《抗衰老秘籍 认识衰老规律 延长人类生命》", 30 June 2013, 湖南科学技术出版社 * |
| 曹劲松等: "《食品营养强化剂》", 31 January 2002 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109874972A (en) * | 2019-04-08 | 2019-06-14 | 深圳津梁生活科技有限公司 | Multifunctional and nutritional compound health snack food |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Choudhary et al. | Consumption of functional food and our health concerns | |
| Ramoutar et al. | Antioxidant and anticancer properties and mechanisms of inorganic selenium, oxo-sulfur, and oxo-selenium compounds | |
| Peñas et al. | Sauerkraut: production, composition, and health benefits | |
| JP5165894B2 (en) | Body fat percentage reducing drug | |
| Sikiru et al. | Chlorella vulgaris supplementation effects on performances, oxidative stress and antioxidant genes expression in liver and ovaries of New Zealand White rabbits | |
| Li et al. | Nutritional strategies to alleviate oxidative stress in sows | |
| Ahmed et al. | The impact of functional food in prevention of malnutrition | |
| CN105639108A (en) | Feed additive capable of preventing animals from being harmed by mycotoxin in feed, production method of feed additive and animal feed | |
| CN107348304A (en) | Effervescent tablet containing Tea Polyphenols and curcumin and preparation method thereof | |
| Sirohi et al. | Food fortification: a nutritional management strategy in India | |
| Garcia et al. | Dietary Supplements of Vitamins E, C, and β-Carotene to Reduce Oxidative Stress in Horses: An Overview | |
| JP2009215170A (en) | Composition for improving metabolism in energy production | |
| JP2007517761A (en) | Anti-aging composition | |
| KR100945462B1 (en) | Food composition for detoxificating heavy metal and health food comprising the same | |
| CN106539093A (en) | A kind of gene repair fully nutrient | |
| JP2006347927A (en) | Fatigue-improving agent | |
| JP2008110942A (en) | Antioxidant composition containing astaxanthin, zinc and selenium | |
| JP2006014730A (en) | Food product | |
| CN107772190A (en) | A kind of Astaxanthin In Haematococcus Pluvialis product formula for improving puerpera and infant immunity | |
| JP2009148240A (en) | Health supplement | |
| WO2021231721A1 (en) | Tetrahydrocurcuminoid-metal complexes, manufacturing methods thereof, and uses thereof | |
| Tokhiriyon et al. | Industrialization issues in the production of specialized products for complex body metabolism support | |
| Al-Tameemi et al. | The medical importance of chlorophylls and their derivatives | |
| Malhotra et al. | A recent paradigm on iron absorption, prevalence, and emerging dietary approaches to eradicate iron deficiency | |
| CN111789837A (en) | Composition for preventing and treating mild and moderate helicobacter pylori infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170329 |